A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment

• Päätekijät: Da Wang (Tekijä), Chao Wang (Tekijä), Liang Wang (Tekijä), Yue Chen (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Taylor & Francis Group, 2019-01-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Glioblastoma (GBM) is the most common and lethal primary brain tumor which is highly resistant to conventional radiotherapy and chemotherapy, and cannot be effectively controlled by surgical resection. Due to inevitable recurrence of GBM, it remains essentially incurable with a median overall surviv...